Response by Thuny et al. to Letter Regarding Article, “Clinical Features, Management, and Outcomes of Immune Checkpoint Inhibitor–Related Cardiotoxicity”
http://api.archives-ouvertes.fr/search/?fq=halId_s:hal-01843016&fl=title_s,en_title_s,docid,label_s,en_label_s,docType_s,authIdHal_s,halId_s,structId_i,uri_s,keyword_s,en_keyword_s,authLastNameFirstName_s,journalTitle_s,abstract_s,en_abstract_s,producedDate_tdate,producedDateY_i,language_s,fileMain_s&sort=publicationDate_s+desc
authors
keywords
- Cardiovascular event
- ICIs
- Endomyocardial biopsy
- Systolic left ventricular dysfunction
document type
OTHERabstract
Response to Letter Regarding Article : Clinical Features, Management, and Outcomes of Immune Checkpoint Inhibitor–Related Cardiotoxicity by Marion Escudier, Jennifer Cautela, Nausicaa Malissen, Yann Ancedy, Morgane Orabona, Johan Pinto, Sandrine Monestier, Jean-Jacques Grob, Ugo Scemama, Alexis Jacquier, Nathalie Lalevee, Jeremie Barraud, Michael Peyrol, Marc Laine, Laurent Bonello, Franck Paganelli, Ariel Cohen, Fabrice Barlesi, Stephane Ederhy, and Franck Thuny. doi.org/10.1161/CIRCULATIONAHA.117.030571
